Refactor Capital is a seed stage VC firm investing in bio, climate, and health.
Business Model:
Revenue: $0
Employees: 0-0
Address: 330 Primrose Rd Ste 201
City: Burlingame
State: CA
Zip: 94010
Country: US
Refactor Capital is a seed-stage VC firm investing in bio, climate, and health. We aim to help create a happier, healthier, and more habitable world via software, technology, and the power of biology. Refactor typically leads or co-leads seed and pre-seed rounds with $1-2M checks.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2022 | Evernow | Series A | 0 |
11/2017 | PathAI | Series A | 11M |
1/2016 | Finova Financial | Seed Round | - |
1/2016 | Call9, Inc. | Series A | 10M |
7/2016 | Trace Genomics | Seed Round | 4M |
4/2021 | Brave Care | Series A | 0 |
3/2017 | Plutoshift | Seed Round | 3.5M |
5/2016 | Clover Health | Series C | 160M |
7/2022 | YourChoice Therapeutics | Series A | 15M |
1/2019 | AKASA | Seed Round | 5M |
7/2022 | FYTO | Series A | 0 |
3/2021 | Spora Health | Seed Round | 3M |
4/2020 | Solugen | Series B | 30M |
5/2021 | PathAI | Series C | 0 |
4/2021 | Ophelia | Series A | 0 |
4/2020 | Red Leader | Seed Round | 3M |
10/2019 | Redesign Science | Seed Round | 2M |
5/2017 | Clover Health | Series D | 130M |
9/2020 | Curative | Seed Round | 8M |
8/2020 | ANA Therapeutics | Seed Round | 5M |
12/2018 | Knowde | Seed Round | 3.5M |
12/2020 | Rubedo Life Sciences | Seed | 12M |
10/2018 | Blockfolio | Series A | 0 |
4/2019 | Vital | Seed Round | 5.2M |
10/2022 | Solugen | Series D | 0 |
9/2017 | Cofactor Genomics | Series A | 18M |
3/2020 | Avail Medsystems | Series A | 0 |
10/2015 | Verge Genomics | Seed Round | 4M |
5/2019 | Solugen | Series B | 32M |
11/2020 | 64x Bio | Seed Round | 4.5M |
10/2018 | Solugen | Series A | 18.8M |
5/2018 | Shield Bio | Series A | 0 |
9/2015 | Headspace Health | Series A | 0 |
10/2018 | Hero Health | Series A | 12M |
5/2022 | Ness | Seed Round | 0 |
8/2019 | Brave Care | Seed Round | 0 |
12/2016 | PathAI | Seed Round | 4.2M |
2/2017 | Shield Bio | Seed Round | 4.1M |
4/2018 | Biobot Analytics | Seed Round | 0 |
4/2016 | Astranis | Seed Round | - |
9/2021 | Solugen | Series C | 0 |
10/2017 | Enzyme | Seed Round | 1.9M |
4/2021 | Orchid Bioscience Inc | Seed Round | 0 |
1/2018 | Uniform Teeth | Seed Round | 4M |
9/2017 | Knowde | Pre Seed Round | 1.3M |
5/2020 | Knowde | Series A | 14M |
12/2022 | Parallel Bio | Seed Round | 4M |
12/2019 | Uniform Teeth | Series A | 10M |
4/2021 | Astranis | Series C | 250M |
8/2016 | Finova Financial | Venture Round | 52.5M |
8/2021 | Knowde | Series B | 72M |
6/2023 | Modulo Bio | Series A | 0 |
3/2016 | Kip | Seed Round | - |
10/2017 | Octant Bio | Seed Round | 5M |
10/2018 | FactoryFour | Series A | 5M |
2/2017 | TL Biolabs | Seed Round | 4M |
2/2019 | Culture Biosciences | Venture Round | 0 |
6/2018 | Checkerspot | Seed Round | 5M |
12/2021 | Phytoform Labs | Seed Round | 0 |
8/2019 | Mori | Seed Round | 0 |
7/2019 | Umbrella | Seed | 5M |
10/2019 | Tempest | Series A | 10M |
9/2017 | Call9, Inc. | Series B | 24M |
5/2020 | Magic | Seed Round | 4M |
10/2017 | Solugen | Seed Round | 4.4M |
12/2021 | Mythic Therapeutics | Series B | 0 |
8/2016 | Legalist | Seed Round | - |
4/2021 | Mori | Series B | 0 |
4/2023 | Macro Oceans | Seed Round | 0 |
1/2022 | 64x Bio | Series A | 0 |
3/2018 | Astranis | Series A | 13.5M |
3/2016 | Alloy | Seed Round | 3.3M |
7/2017 | Gencove | Seed Round | 0 |
4/2015 | PicnicHealth | Seed | 2M |
5/2019 | Kin Euphorics | Venture Round | 5M |
7/2020 | Mori | Series A | 0 |
3/2022 | Mori | Series B | 0 |
1/2023 | Melonfrost | Seed Round | 7M |
5/2020 | Ophelia | Seed Round | 2.7M |
12/2021 | Ophelia | Series B | 0 |
12/2018 | Cambridge Cancer Genomics | Seed Round | 4.5M |
7/2022 | YourChoice Therapeutics | Series A | 0 |
7/2022 | FYTO | Series A | 0 |
5/2022 | Ness | Seed Round | 0 |
4/2022 | Evernow | Series A | 0 |
3/2022 | Mori | Series B | 0 |
1/2022 | 64x Bio | Series A | 0 |
12/2021 | Phytoform Labs | Seed Round | 0 |
12/2021 | Mythic Therapeutics | Series B | 0 |
12/2021 | Ophelia | Series B | 0 |
9/2021 | Solugen | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|